Shareholders' Equity So, based on the above formula, the ROE for Greenfire Resources is: 5.1% = CA$38m ÷ CA$742m (Based on the trailing twelve months to September 2024). The 'return' is the yearly ...
Nattawat Klomjit, MD, shares insights on managing IgA nephropathy and C3 glomerulopathy, including innovative drugs that target kidney inflammation and proteinuria.